This study – led by Nishant Srinivasan, from the University of Illinois – looked at how AKI affected the health of very-low-birthweight (VLBW)babies. The researchers studied 447 VLBW babies admitted to a neonatal intensive care unit between July 2009 and April 2015. They found that the incidence of AKI was 19.5%. Patent ductus arteriosus (a congenital heart defect) and the use of the antibiotic vancomycin were both significantly associated with AKI. The babies with AKI were more likely to die, have lung problems, have higher levels of a substance called creatinine (used to measure kidney function) for longer and their median length of stay in hospital was longer by 38 days.
You can read the abstract of this article here.